INO-3107 With Electroporation (EP) in Participants With HPV-6- and/or HPV-11-Associated Recurrent Respiratory Papillomatosis (RRP)
Condition: Respiratory Papillomatosis Interventions: Drug: INO-3107; Device: CELLECTRA™ 2000 Sponsor: Inovio Pharmaceuticals Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials